Intranasal Drug and Vaccine Delivery Market Size to Worth Around USD 60 Billion by 2028
The report analyzes and forecasts the Intranasal Drug and Vaccine Delivery Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Intranasal Drug and Vaccine Delivery Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Intranasal Drug and Vaccine Delivery Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Intranasal Drug and Vaccine Delivery Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2175
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
Participants include major global Aegis Therapeutics LLC, AstraZeneca PlcMedImmune, Inc., Alza Corporation, Baxter International, Inc., Becton, Dickinson and Company, GlaxoSmithKline Plc., Johnson & Johnson, Inc., and Others.
The major market segments of Intranasal Drug and Vaccine Delivery Market are as below:
Intranasal Drug and Vaccine Delivery Market By Product
Liquid Delivery Device
Powder Delivery Device
Pressurized Metered Dose Inhaler
Others
Intranasal Drug and Vaccine Delivery Market By Application
Neurological Disorder
Pain Management
Respiratory Disorders
Vaccination
Others
Intranasal Drug and Vaccine Delivery Market By End Use
Retail Outlets
Hospital Pharmacies
Online Platform
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1.Industry Overview of Intranasal Drug and Vaccine Delivery
1.1.Definition and Scope
1.1.1.Definition of Intranasal Drug and Vaccine Delivery
1.1.2.Market Segmentation
1.1.3.Years Considered for the Study
1.1.4.Assumptions and Acronyms Used
1.1.4.1.Market Assumptions and Market Forecast
1.1.4.2.Acronyms Used in Global Intranasal Drug and Vaccine Delivery Market
1.2.Summary
1.2.1.Executive Summary
1.2.2.Intranasal Drug and Vaccine Delivery Market By Product
1.2.3.Intranasal Drug and Vaccine Delivery Market By Application
1.2.4.Intranasal Drug and Vaccine Delivery Market By End Use
1.2.5.Intranasal Drug and Vaccine Delivery Market by Regions
CHAPTER 2.Research Approach
2.1.Methodology
2.1.1.Research Programs
2.1.2.Market Size Estimation
2.1.3.Market Breakdown and Data Triangulation
2.2.Data Source
2.2.1.Secondary Sources
2.2.2.Primary Sources
CHAPTER 3.Market Dynamics And Competition Analysis
3.1.Market Drivers
3.1.1.Driver 1
3.1.2.Driver 2
3.2.Restraints and Challenges
3.2.1.Restrain 1
3.2.2.Restrain 2
3.3.Growth Opportunities
3.3.1.Opportunity 1
3.3.2.Opportunity 2
3.4.Porter’s Five Forces Analysis
3.4.1.Bargaining Power of Suppliers
3.4.2.Bargaining Power of Buyers
3.4.3.Threat of Substitute
3.4.4.Threat of New Entrants
3.4.5.Degree of Competition
3.5.Market Concentration Ratio and Market Maturity Analysis of Intranasal Drug and Vaccine Delivery Market
3.5.1.Go To Market Strategy
3.5.1.1.Introduction
3.5.1.2.Growth
3.5.1.3.Maturity
3.5.1.4.Saturation
3.5.1.5.Possible Development
3.6.Technological Roadmap for Intranasal Drug and Vaccine Delivery Market
3.7.Value Chain Analysis
3.7.1.List of Key Manufacturers
3.7.2.List of Customers
3.7.3.Level of Integration
3.8.Cost Structure Analysis
3.8.1.Price Trend of Key Raw Materials
3.8.2.Raw Material Suppliers
3.8.3.Proportion of Manufacturing Cost Structure
3.8.3.1.Raw Material
3.8.3.2.Labor Cost
3.8.3.3.Manufacturing Expense
3.9.Regulatory Compliance
3.10.Competitive Landscape, 2020
3.10.1.Player Positioning Analysis
3.10.2.Key Strategies Adopted By Leading Players
CHAPTER 4.Manufacturing Plant Analysis
4.1.Manufacturing Plant Location and Establish Date of Major Manufacturers in 2020
4.2.R&D Status and Application Source of Intranasal Drug and Vaccine Delivery Major Manufacturers in 2020
CHAPTER 5.Intranasal Drug and Vaccine Delivery Market By Product
5.1.Introduction
5.2.Intranasal Drug and Vaccine Delivery Revenue By Product
5.2.1.Intranasal Drug and Vaccine Delivery Revenue (US$ Mn) and Forecast, By Product, 2017-2028
5.2.2.Liquid Delivery Device
5.2.2.1.Liquid Delivery Device Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.3.Powder Delivery Device
5.2.3.1.Powder Delivery Device Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.4.Pressurized Metered Dose Inhaler
5.2.4.1.Pressurized Metered Dose Inhaler Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
5.2.5.Others
5.2.5.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 6.Intranasal Drug and Vaccine Delivery Market Revenue By Application
6.1.Introduction
6.2.Intranasal Drug and Vaccine Delivery Revenue (US$ Mn) By Application
6.2.1.Intranasal Drug and Vaccine Delivery Revenue (US$ Mn) and Forecast By Application, 2017 – 2028
6.2.2.Neurological Disorder
6.2.2.1.Neurological Disorder Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.3.Pain Management
6.2.3.1.Pain Management Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.4.Respiratory Disorders
6.2.4.1.Respiratory Disorders Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.5.Vaccination
6.2.5.1.Vaccination Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
6.2.6.Others
6.2.6.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 7.Intranasal Drug and Vaccine Delivery Market By End Use
7.1.Introduction
7.2.Intranasal Drug and Vaccine Delivery Revenue (US$ Mn) By End Use
7.2.1.Intranasal Drug and Vaccine Delivery Revenue (US$ Mn) and Forecast By End Use, 2017 – 2028
7.2.2.Retail Outlets
7.2.2.1.Retail Outlets Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.3.Hospital Pharmacies
7.2.3.1.Hospital Pharmacies Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
7.2.4.Online Platform
7.2.4.1.Online Platform Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028
CHAPTER 8.North America Market By Country
8.1.North America Overview
8.2.U.S.
8.2.1.U.S. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
8.2.2.U.S. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
8.2.3.U.S. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
8.3.Canada
8.3.1.Canada Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
8.3.2.Canada Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
8.3.3.Canada Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
8.4.North America PEST Analysis
CHAPTER 9.Europe Market By Country
9.1.Europe Market Overview
9.2.U.K.
9.2.1.U.K. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
9.2.2.U.K. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.2.3.U.K. Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.3.Germany
9.3.1.Germany Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
9.3.2.Germany Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.3.3.Germany Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.4.France
9.4.1.France Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
9.4.2.France Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.4.3.France Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.5.Spain
9.5.1.Spain Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
9.5.2.Spain Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.5.3.Spain Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.6.Rest of Europe
9.6.1.Rest of Europe Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017-2028
9.6.2.Rest of Europe Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017-2028
9.6.3.Rest of Europe Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017-2028
9.7.Europe PEST Analysis
CHAPTER 10.Asia Pacific Market By Country
10.1.Asia Pacific Market Overview
10.2.China
10.2.1.China Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 – 2028
10.2.2.China Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 – 2028
10.2.3.China Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 – 2028
10.3.Japan
10.3.1.Japan Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 – 2028
10.3.2.Japan Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 – 2028
10.3.3.Japan Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 – 2028
10.4.India
10.4.1.India Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 – 2028
10.4.2.India Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 – 2028
10.4.3.India Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 – 2028
10.5.Australia
10.5.1.Australia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 – 2028
10.5.2.Australia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 – 2028
10.5.3.Australia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 – 2028
10.6.South Korea
10.6.1.South Korea Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 – 2028
10.6.2.South Korea Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 – 2028
10.6.3.South Korea Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 – 2028
10.7.Rest of Asia-Pacific
10.7.1.Rest of Asia-Pacific Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 – 2028
10.7.2.Rest of Asia-Pacific Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 – 2028
10.7.3.Rest of Asia-Pacific Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 – 2028
10.8.Asia Pacific PEST Analysis
CHAPTER 11.Latin America Market By Country
11.1.Latin America Market Overview
11.2.Brazil
11.2.1.Brazil Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 – 2028
11.2.2.Brazil Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 – 2028
11.2.3.Brazil Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 – 2028
11.3.Mexico
11.3.1.Mexico Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 – 2028
11.3.2.Mexico Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 – 2028
11.3.3.Mexico Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 – 2028
11.4.Rest of Latin America
11.4.1.Rest of Latin America Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 – 2028
11.4.2.Rest of Latin America Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 – 2028
11.4.3.Rest of Latin America Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 – 2028
CHAPTER 12.Middle East & Africa Market By Country
12.1.Middle East & Africa Market Overview
12.2.Saudi Arabia
12.2.1.Saudi Arabia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 – 2028
12.2.2.Saudi Arabia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 – 2028
12.2.3.Saudi Arabia Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 – 2028
12.3.UAE
12.3.1.UAE Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 – 2028
12.3.2.UAE Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 – 2028
12.3.3.UAE Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 – 2028
12.4.Rest of Middle East & Africa
12.4.1.Rest of Middle East & Africa Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Product, 2017 – 2028
12.4.2.Rest of Middle East & Africa Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By Application, 2017 – 2028
12.4.3.Rest of Middle East & Africa Intranasal Drug and Vaccine Delivery Market Revenue (US$ Mn) and Forecast By End Use, 2017 – 2028
CHAPTER 13.Player Analysis Of Intranasal Drug and Vaccine Delivery
13.1.Intranasal Drug and Vaccine Delivery Market Company Share Analysis
13.2.Competition Matrix
13.2.1.Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2.New Product Launches and Product Enhancements
13.2.3.Mergers And Acquisition In Global Intranasal Drug and Vaccine Delivery Market
13.2.4.Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14.COMPANY PROFILE
14.1.Aegis Therapeutics LLC
14.1.1.Company Snapshot
14.1.2.Business Overview
14.1.3.Financial Overview
14.1.3.1.Revenue (US$ Mn), 2020
14.1.3.2.Aegis Therapeutics LLC 2020 Intranasal Drug and Vaccine Delivery Business Regional Distribution
14.1.4.Product/ Service and Specification
14.1.5.Recent Developments & Business Strategy
14.1.6.Manufacturing Plant Footprint Analysis
14.2.AstraZeneca Plc
14.3.MedImmune, Inc.
14.4.Alza Corporation
14.5.Baxter International, Inc.
14.6.Becton, Dickinson and Company
14.7.GlaxoSmithKline Plc.
14.8.Johnson & Johnson, Inc.
14.9.Others
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/2175
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
